Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit-harm balance modeling study.

导出 OA

翻译打印收藏纠错

作者： Henock G,Yebyo ^[1] ; Hélène E,Aschmann ^[2] ; Dominik,Menges ^[2] ; Cynthia M,Boyd ^[3] ; Milo A,Puhan ^[2]

作者单位： Epidemiology, Biostatistics & Prevention Institute, University of Zurich, Hirschengraben 84, Zurich, CH-8001, Switzerland. ^[1] Department of Epidemiology; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland. ^[2] The Johns Hopkins University, School of Medicine, Baltimore, MD, USA. ^[3]

关键词 benefit–harm balance cardiovascular disease risk threshold lipid-lowering drugs primary CVD prevention statins

DOI 10.1177/2040622319877745

PMID 31598209

发布时间 2024-07-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Therapeutic advances in chronic disease

2019年10卷

2040622319877745页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit-harm balance modeling study.

Therapeutic advances in chronic disease

相似文献

Therapeutic advances in chronic disease

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit-harm balance modeling study.

Therapeutic advances in chronic disease

相似文献

Therapeutic advances in chronic disease

相关期刊

检索历史清除